Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

An2 Therapeutics, Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
ANTX
Anadolu Efes Biracilik Ve Malt Sanayi A S
Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi, together with its subsidiaries, engages in the production, bottling, distribution, and sale of beer, malt, and non-alcoholic beverages in Turkey and internationally. It operates in two segments, Beer Group and Soft Drinks. The company is also involved in the production, bottling, distribution, and sale of carbonated and still non-alcoholic beverages, fruit juice concentrates, purees and fresh fruit, and carbonated soft drinks under the Coca-Cola Company trademark; and filling of spring water beverages. In addition, it leases intellectual property and related products.
AEBZY
Analog Devices Inc
Analog Devices is a leading analog, mixed-signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
ADI
Anaptysbio, Inc
AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.
ANAB
Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2.
AVXL
Anbio Biotechnology
Anbio Biotechnology is a globally oriented in vitro diagnostics (IVD) company providing a broad range of solutions, including immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, rapid testing and veterinary diagnostics. With operations across multiple regions, the company works to enhance the availability of reliable and timely diagnostics, supporting better decision-making in healthcare settings worldwide.
NNNN
Andersen Group Inc.
No description
ANDG
Andersons, Inc.
The Andersons, Inc. , is a North American agriculture and renewable fuels company that conducts business in the agribusiness and renewables sectors. Guided by its Statement of Principles, The Andersons is committed to providing extraordinary service to its customers, helping its employees improve, supporting its communities, and increasing the value of the company. For more information, please visit www.andersonsinc.com .
ANDE
Andina Bottling Co Inc
No description
AKO-A
Andretti Acquisition Corp. Ii
No description
POLE
Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
ANEB
Anew Health Ltd
No description
AVG
Anfield Energy Inc.
Anfield Energy Inc is a uranium and vanadium development and near-term production company. Anfield's conventional uranium asset portfolio is underpinned by Shootaring Canyon Mill - one of only three licensed, permitted and constructed conventional uranium mills in the US - located in Utah. Anfield's West Slope project in Colorado has a historical uranium and vanadium resource of 11mlbs and 53Mlbs, respectively, while Utah-based Velvet-Wood project has an NI 43-101 uranium resource of 4.6Mlbs.
AEC
Angel Oak Financial Strategies Income Term Trust
The Fund will under normal circumstances invest at least 80% of the value of its net assets plus the amount of any borrowings for investment purposes in the securities of financial institutions measured at the time of purchase. For purposes of the Fund 80% investment policy the Fund may invest in debt securities including subdebt unrated debt senior debt preferred securities high yield securities and TruPS equity securities including common equity preferred equity convertible securities and warrants... In pursuing its investment objective, the Fund invests primarily in debt issued by financial institutions, including subordinated debt (sub-debt), unrated debt, senior debt and high yield securities, focusing on those in the U.S. community bank sector. The Fund may also invest in common equity, preferred equity, convertible securities and warrants of these institutions.
FINS
Angel Oak Mortgage Reit, Inc.
Angel Oak Mortgage Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.
AOMR
Angel Oak Strategic Credit Fund
No description
ASCIX
Angel Studios, Inc.
Angel Studios, Inc. produce and distribute films and television shows by creators through its streaming platform. The company's platform allows users to watch movies, shows, and documentaries for all ages. In addition, the company sells physical media, such as DVD, Blu-ray discs, and various books online, and provides content licensing services. The platform allows fans to invest in and promote productions, fostering a community-driven approach to content creation. Angel Studios, Inc. was formerly known as VidAngel, Inc. and changed its name to Angel Studios, Inc. in March 2021. The company was founded in 2013 and is based in Provo, Utah.
ANGX
Anghami Inc
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the largest catalog of songs.
ANGH
Angi Inc.
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair; and Europe, which includes the operations of Travaux, MyHammer, MyBuilder, Werkspot, and Instapro. The company generates maximum revenue from the North American segment.
ANGI
Angiodynamics Inc
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, it derives a majority of revenue from the United States.
ANGO
Angle Plc
CelLBxHealth plc is a global precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be seamlessly integrated with existing laboratory instruments for comprehensive downstream analysis including whole-cell imaging, proteomic profiling and full genomic workflows.Commercial activities focus on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships. (2) Lab Developed Tests (LDTs): Strategic partnerships combined with a focused in-house development programme (3) Laboratory services: Clinical trial support and assay development.The product portfolio comprises the Parsortix® platform with associated consumables and assays.
ANPCY
Anglogold Ashanti Plc
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
AU
Anheuser-busch Inbev Sa
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. After the SABMiller acquisition, the company's portfolio now contains five of the top 10 beer brands by sales and 18 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and U.S.-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev and in 2016 acquired SABMiller.
BUD
Ani Pharmaceuticals Inc
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of 'Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S. -based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
ANIP
Anika Therapeutics, Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of revenue from the United States.
ANIK
Anixa Biosciences Inc
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against 'retired' proteins that have been found to be expressed in certain forms of cancer.
ANIX
Ankam, Inc.
No description
ANKM
Annaly Capital Management Inc
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
NLY
Annexon, Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexon's product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases.
ANNX
Annovis Bio, Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
ANVS